Bicycle Therapeutics BCYC
NASDAQ BCYC
$4.30 +0.06 (+1.42%)
At close: Sep 4, 2026 · 4:00 PM EDT

Bicycle Therapeutics (BCYC) Asset Utilization Ratio (2019 - 2026)

Bicycle Therapeutics' (BCYC) quarterly Asset Utilization Ratio came in at 0.1 in Q2 2026, up 332.69% YoY from 0.02 in Q2 2025, and up 4.89% on a QoQ basis from 0.09 in Q1 2026.

Analysis

Bicycle Therapeutics (BCYC) Asset Utilization Ratio (2019 - 2026) Analysis & Trends

Bicycle Therapeutics (BCYC) has 8 years of Asset Utilization Ratio data on file, last reported at 0.1 in Q2 2026.

  • Quarterly Asset Utilization Ratio rose 332.69% year-over-year to 0.1 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.1 (up 332.69% YoY) and the FY2025 annual result came in at 0.09, up 90.75% from the prior year.
  • Asset Utilization Ratio rose to 0.1 in Q2 2026, from 0.09 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.1 in Q4 2025 to a low of 0.02 in Q2 2025.
  • A 5-year average of 0.05 and a median of 0.04 in 2023 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2022 — Asset Utilization Ratio slumped 57.13% — and 2026, when it jumped 332.69%.
  • Tracing BCYC's Asset Utilization Ratio over 5 years: stood at 0.06 in 2022, then fell by 23.65% to 0.04 in 2023, then slumped by 38.78% to 0.03 in 2024, then jumped by 266.09% to 0.1 in 2025, then fell by 0.77% to 0.1 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.1 (Q2 2026), 0.09 (Q1 2026), and 0.1 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 0.38
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 0.20
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 0.69
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 0.90
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.13
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 0.54
10 Bicycle Therapeutics 299.81 Mn 299.81 Mn - 0.10
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.10
Mar 31, 2026 0.09
Dec 31, 2025 0.10
Sep 30, 2025 0.04
Jun 30, 2025 0.02
Mar 31, 2025 0.03
Dec 31, 2024 0.04
Sep 30, 2024 0.04
Jun 30, 2024 0.05
Mar 31, 2024 0.07
Dec 31, 2023 0.04
Sep 30, 2023 0.05
Jun 30, 2023 0.06
Mar 31, 2023 0.06
Dec 31, 2022 0.06
Sep 30, 2022 0.04
Jun 30, 2022 0.04
Mar 31, 2022 0.02
Dec 31, 2021 0.03
Sep 30, 2021 0.05